Get started
Author

Grégoire Berthod

Observed names: G Berthod, G. Berthod, G., Berthod, Gregoire Berthod
Observed institutions: Centre Hospitalier Universitaire Vaudois, University Hospital of Geneva, Hôpital Orthopédique de la Suisse Romande, Hôpital de Morges, Hôpital de Sion, Hôpital du Valais, University of Lausanne
ORCID: 0009-0002-8893-5240
Observed ORCID: 0009-0002-8893-5240
OpenAlex ID: A5046496560
Pulmonary Sarcoid-Like Granulomatosis Induced by Ipilimumab
2012 · Grégoire Berthod, Romain Lazor, et al. · Journal of Clinical Oncology · 185
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma
2024 · David Barras, Eleonora Ghisoni, et al. · Science Immunology · 108
PDF
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
2015 · Amandine Legat, Hélène Maby-El Hajjami, et al. · Clinical Cancer Research · 95
PDF
Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
2015 · C. Driessen, M. Kraus, et al. · Haematologica · 60
PDF
Vaccination‐induced functional competence of circulating human tumor‐specific CD8 T‐cells
2011 · Petra Baumgaertner, Camilla Jandus, et al. · International Journal of Cancer · 52
PDF
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)
2011 · K. Zaman, B. Thürlimann, et al. · Annals of Oncology · 42
PDF
The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study
2019 · Filipe Martins, Luis Schiappacasse, et al. · Journal of Neuro-Oncology · 36
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study
2022 · David Sibon, Bettina Bisig, et al. · Haematologica · 33
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient
2019 · Vincent Pillonel, Vincent Dunet, et al. · Journal for ImmunoTherapy of Cancer · 23
PDF
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial
2013 · F. Hitz, N. Fischer, et al. · Annals of Hematology · 22
BRAF V600E mutation: A treatable driver mutation in pleomorphic xanthoastrocytoma (PXA)
2015 · Silvia Hofer, Grégoire Berthod, et al. · Acta Oncologica · 20
PDF
Solitary Choriocarcinoma in the Lung
2010 · Grégoire Berthod, Hanifa Bouzourene, et al. · Journal of Thoracic Oncology · 19
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma
2022 · Veronica Aedo-Lopez, Camille L. Gérard, et al. · Cancers · 17
PDF
Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
2022 · Bianca Gautron Moura, Camille Gerard, et al. · Cancers · 7
PDF
Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis
2019 · Bassel Hallak, Anne Cairoli, et al. · BMJ Case Reports · 6
PDF
Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy
2025 · Cristina-Maria Florea, Laurent Parmentier, et al. · Case Reports in Oncology · 5
Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease
2014 · Daniel Gero, Vanessa Queiros da Mota, et al. · Melanoma Research · 4
Severe Colitis in 2 Patients with Melanoma Treated with BRAF/MEK Inhibitors: Case Report and Literature Review
2024 · Chloe Wautier, Jolanta Gourmaud, et al. · Case Reports in Oncology · 2
PDF
Nouvelles [b]immunothérapies[/b] du mélanome : mécanismes d’action, efficacité et prise en charge des toxicités
2015 · Bianca Moura, Krisztian Homicsko, et al. · JMIG · 2
Sorafenib plus selective internal radiotherapy with 90Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial
2025 · Grégoire Berthod, Christophe Cisarovsky, et al. · British Journal of Cancer · 1
PDF
Risk Factors for Arterial Thromboembolic Events in Male Germ Cell Tumors Treated with Chemotherapy
2025 · Daniele Frisone, Melinda Charrier, et al. · Cancers · 1
PDF
Inhibiteurs de la PARP : une meilleure sélection des patient-e-s
2023 · Marc Senglet, Grégoire Berthod, et al. · JMIG · 1
Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients.
2021 · Bianca Gautron Moura, Camille Léa Gérard, et al. · Journal of Clinical Oncology · 1
Unsorted single-cell RNA sequencing profiles of metastatic melanoma patients reveal the heterogeneity of melanoma-associated fibroblasts
2019 · K. Homicsko, D. Barras, et al. · Annals of Oncology · 1
[Diarrhea caused by systemic anti-cancer treatments].
2016 · Irma Dischl-Antonioni, Grégoire Berthod, et al. · PubMed · 1
Works count: 52
Citation count: 748
H-index: 13
I10-index: 13
Year
Topic
Type